Zobrazeno 1 - 10
of 175
pro vyhledávání: '"Fumihiko, Ishikawa"'
Autor:
Tomoya Isobe, Masatoshi Takagi, Aiko Sato-Otsubo, Akira Nishimura, Genta Nagae, Chika Yamagishi, Moe Tamura, Yosuke Tanaka, Shuhei Asada, Reina Takeda, Akiho Tsuchiya, Xiaonan Wang, Kenichi Yoshida, Yasuhito Nannya, Hiroo Ueno, Ryo Akazawa, Itaru Kato, Takashi Mikami, Kentaro Watanabe, Masahiro Sekiguchi, Masafumi Seki, Shunsuke Kimura, Mitsuteru Hiwatari, Motohiro Kato, Shiro Fukuda, Kenji Tatsuno, Shuichi Tsutsumi, Akinori Kanai, Toshiya Inaba, Yusuke Shiozawa, Yuichi Shiraishi, Kenichi Chiba, Hiroko Tanaka, Rishi S. Kotecha, Mark N. Cruickshank, Fumihiko Ishikawa, Tomohiro Morio, Mariko Eguchi, Takao Deguchi, Nobutaka Kiyokawa, Yuki Arakawa, Katsuyoshi Koh, Yuki Aoki, Takashi Ishihara, Daisuke Tomizawa, Takako Miyamura, Eiichi Ishii, Shuki Mizutani, Nicola K. Wilson, Berthold Göttgens, Satoru Miyano, Toshio Kitamura, Susumu Goyama, Akihiko Yokoyama, Hiroyuki Aburatani, Seishi Ogawa, Junko Takita
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-16 (2022)
The molecular heterogeneity of KMT2A-rearranged infant acute lymphoblastic leukemia (ALL) remains poorly characterised. Here, the authors perform multi-omics analysis for 84 ALL patients and suggest 5 distinct subgroups for risk stratification and pe
Externí odkaz:
https://doaj.org/article/7fee3de7cd6b4b10b237a1df0b62b1d6
Autor:
Rintaro Ono, Takashi Watanabe, Eiryo Kawakami, Makoto Iwasaki, Mariko Tomizawa-Murasawa, Masashi Matsuda, Yuho Najima, Shinsuke Takagi, Saera Fujiki, Rumi Sato, Yoshiki Mochizuki, Hisahiro Yoshida, Kaoru Sato, Hiromasa Yabe, Shunichi Kato, Yoriko Saito, Shuichi Taniguchi, Leonard D. Shultz, Osamu Ohara, Masayuki Amagai, Haruhiko Koseki, Fumihiko Ishikawa
Publikováno v:
EBioMedicine, Vol 41, Iss , Pp 584-596 (2019)
Background: Graft-versus host disease (GVHD) is a complication of stem cell transplantation associated with significant morbidity and mortality. Non-specific immune-suppression, the mainstay of treatment, may result in immune-surveillance dysfunction
Externí odkaz:
https://doaj.org/article/280692afcb6f4d14804164565b679c85
Autor:
Anne P. de Groot, Yoriko Saito, Eiryo Kawakami, Mari Hashimoto, Yuki Aoki, Rintaro Ono, Ikuko Ogahara, Saera Fujiki, Akiko Kaneko, Kaori Sato, Hiroshi Kajita, Takashi Watanabe, Masatoshi Takagi, Daisuke Tomizawa, Katsuyoshi Koh, Mariko Eguchi, Eiichi Ishii, Osamu Ohara, Leonard D. Shultz, Shuki Mizutani, Fumihiko Ishikawa
Publikováno v:
EBioMedicine, Vol 64, Iss , Pp 103235- (2021)
Background: Acute lymphoblastic leukaemia with mixed lineage leukaemia gene rearrangement (MLL-ALL) frequently affects infants and is associated with a poor prognosis. Primary refractory and relapsed disease due to resistance to glucocorticoids (GCs)
Externí odkaz:
https://doaj.org/article/3aa6dbea41224ab8aabce9173df53e80
Autor:
Jane Chuprin, Hannah Buettner, Mina O. Seedhom, Dale L. Greiner, James G. Keck, Fumihiko Ishikawa, Leonard D. Shultz, Michael A. Brehm
Publikováno v:
Nature Reviews Clinical Oncology. 20:192-206
Publikováno v:
Nippon Daicho Komonbyo Gakkai Zasshi. 76:8-13
Autor:
Hiroshi Ito, Hiroshi Nitta, Masafumi Mizuide, Motonori Arai, Yuki Tanisaka, Hiroyuki Eto, Shigeyuki Kamata, Yoshihisa Fujita, Taro Ogino, Moriyasu Nakahara, Yosuke Miyahara, Toyotaka Kasai, Fumihiko Ishikawa, Koichi Kawabe, Shomei Ryozawa, Seiji Muramatsu
Publikováno v:
Suizo. 36:104-111
Autor:
Yuya YAMAMOTO, Yoshihisa FUJITA, Fumihiko ISHIKAWA, Hiroshi NITTA, Shigeyuki KAMATA, Hiroshi ITO
Publikováno v:
Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 82:1148-1152
Autor:
Hiroshi Ito, Shigeyuki Kamata, Hiroshi Nitta, Fumihiko Ishikawa, Yoshihisa Fujita, Yoshihisa Takahashi
Publikováno v:
Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 81:709-713
Publikováno v:
Nippon Daicho Komonbyo Gakkai Zasshi. 73:244-251
Autor:
Mari, Hashimoto, Fumihiko, Ishikawa
Publikováno v:
[Rinsho ketsueki] The Japanese journal of clinical hematology. 62(7)
Genetic complexity and heterogeneity have made drug discovery difficult in human malignancies. In the past few years, we aimed to find vulnerabilities in therapy-resistant and refractory acute myeloid leukemia (AML) through integrative analyses of ge